Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT06953960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Southern California /ID# 272414 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 272447 New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
  • University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
View all 48 locations
View Trial Details
Recruiting

A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma

NCT06934044

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Tianjin Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • The First Affiliated Hospital of Wenzhou Medical University Wenzhou, China
View Trial Details
Recruiting

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

NCT06500884

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Icahn School of Medicine at Mt. Sinai New York, United States
View all 38 locations
View Trial Details
Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma

NCT06768489

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Monash Medical Centre Clayton, Australia
  • St Vincents Hospital Melbourne Fitzroy, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Calvary Mater Newcastle Hospital Waratah, Australia
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

NCT07149857

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

NCT07030517

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • M S Ramaiah Medical College and Hospital Bangalore, India
  • St. Johns Medical College And Hospital Bengaluru, India
  • Post Graduate Institute of Medical Education And Research PGIMER Chandigarh, India
  • Bhagwan Mahaveer Cancer Hospital & Research Centre Jaipur, India
View Trial Details
Recruiting

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

NCT05201781

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Cancer Center-Scottsdale Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 50 locations
View Trial Details
Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

NCT07266441

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • O Neal Comprehensive Cancer Center at UAB Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 69 locations
View Trial Details
Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

NCT05552222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UCSF Fresno Clovis, California, United States
  • City of Hope Duarte Duarte, California, United States
View all 270 locations
View Trial Details

Related conditions